Abstract
Nucleotide-excision repair diseases exhibit cancer, complex developmental disorders and neurodegeneration. Cancer is the hallmark of xeroderma pigmentosum (XP), and neurodegeneration and developmental disorders are the hallmarks of Cockayne syndrome and trichothiodystrophy. A distinguishing feature is that the DNA-repair or DNA-replication deficiencies of XP involve most of the genome, whereas the defects in CS are confined to actively transcribed genes. Many of the proteins involved in repair are also components of dynamic multiprotein complexes, transcription factors, ubiquitylation cofactors and signal-transduction networks. Complex clinical phenotypes might therefore result from unanticipated effects on other genes and proteins.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Bootsma, D., Kraemer, K. H., Cleaver, J. E. & Hoeijmakers, J. H. J. in The Genetic Basis of Human Cancer (eds. Vogelstein, B. & Kinzler, K. W.) 245–274 (McGraw-Hill, New York, 1998).
Wood, R. D., Mitchell, M., Sgouros, J. & Lindahl, T. Human DNA repair genes. Science 291, 1284–1289 (2001).
Batty, D. P. & Wood, R. W. Damage recognition in nucleotide excision repair of DNA. Gene 241, 193–204 (2000).
Riedl, T., Hanaoka, F. & Egly, J. M. The comings and goings of nucleotide excision repair factors on damaged DNA. EMBO J. 22, 5293–5303 (2003).
Sancar, A., Lindsey-Boltz, L. A., Unsal-Kacmaz, K. & Linn, S. Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu. Rev. Biochem. 73, 39–85 (2004).
Balajee, A. S., Dianova, I. & Bohr, V. A. Oxidative damage-induced PCNA complex formation is efficient in xeroderma pigmentosum group A but reduced in Cockayne syndrome group B cells. Nucleic Acids Res. 27, 4476–4482 (1999).
Svejstrup, J. Q. Rescue of arrested RNA polymerase II complexes. J. Cell Sci. 116, 447–451 (2003).
Volker, M. et al. Sequential assembly of the nucleotide excision repair factors in vivo. Mol. Cell 8, 213–224 (2001).
Nichols, A. F. et al. Human damage-specific DNA binding protein p48. Characterization of XPE mutations and regulation following UV irradiation. J. Biol. Chem. 275, 21422–21428 (2001).
Masutani, C. et al. Purification and cloning of a nucleotide excision repair complex involving the xeroderma pigmentosum group C protein and a human homologue of yeast RAD23. EMBO J. 13, 1831–1843 (1994).
Cleaver, J. E., Thompson, L. H., Richardson, A. S. & States, J. C. A summary of mutations in the UV-sensitive disorders: xeroderma pigmentosum, Cockayne syndrome, and trichothiodystrophy. Hum. Mut. 14, 9–22 (1999).
Itoh, T., Linn, S., Ono, T. & Yamaizumi, M. Reinvestigation of the classification of five cell strains of xeroderma pigmentosum group E with reclassification of three of them. J. Invest. Dermatol. 114, 1022–1029 (2000).
Tang, J. & Chu, G. Xeroderma pigmentosum complementation group E and UV-damaged DNA-binding protein. DNA Repair 1, 601–616 (2002).
Hwang, B. J., Ford, J. M., Hanawalt, P. C. & Chu, G. Expression of the p48 xeroderma pigmentosum gene is p53-dependent and is involved in global genome repair. Proc. Natl Acad. Sci. USA 96, 424–428 (1999).
Tang, J. Y., Hwang, B. J., Ford, J. M., Hanawalt, P. C. & Chu, G. Xeroderma pigmentosum p48 gene enhances global genomic repair and suppresses UV-induced mutagenesis. Mol. Cell 5, 737–744 (2000).
Liu, W. et al. Nuclear transport of human DDB protein induced by ultraviolet light. J. Biol. Chem. 275, 21429–21434 (2000).
Shiyanov, P. et al. The naturally occurring mutants of DDB are impaired in stimulating nuclear import of the p125 subunit and E2F1-activated transcription. Mol. Cell Biol. 19, 4935–4943 (1999).
Tan, T. & Chu, G. p53 Binds and activates the xeroderma pigmentosum DDB2 gene in humans but not mice. Mol. Cell Biol. 22, 3247–3254 (2002).
Painter, R. B. & Cleaver, J. E. Repair replication, unscheduled DNA synthesis, and the repair of mammalian DNA. Radiat. Res. 37, 451–466 (1969).
Shivji, M. K., Eker, A. P. & Wood, R. D. DNA repair defect in xeroderma pigmentosum group C and complementing factor from HeLa cells. J. Biol. Chem. 269, 22749–22757 (1994).
Sugasawa, K. et al. Xeroderma pigmentosum group C protein complex is the initiator of global nucleotide excision repair. Mol. Cell 2, 223–232 (1998).
Wood, R. D. DNA damage recognition during nucleotide excision repair in mammalian cells. Biochimie 81, 39–44 (1999).
Wang, Q. E., Zhu, Q., Wani, G., Chen, J. & Wani, A. A. UV radiation-induced XPC translocation within chromatin is mediated by damaged-DNA binding protein, DDB2. Carcinogenesis 25, 1033–1043 (2004).
Consortium, I. H. G. S. Finishing the euchromatic sequence of the human genome. Nature 431, 931–945 (2004).
Boon, W. M. et al. A comparative analysis of transcribed genes in the mouse hypothalamus and neocortex reveals chromosomal clustering. Proc. Natl Acad. Sci. USA 101, 14972–14977 (2004).
Wood, R. D. Nucleotide excision repair in mammalian cells. J. Biol. Chem. 272, 23465–23468 (1997).
Sancar, A. DNA excision repair. Annu. Rev. Biochem. 65, 43–81 (1996).
Araki, M. et al. Centrosome protein centrin 2/caltractin 1 is part of the xeroderma pigmentosum group C complex that initiates global nucleotide excision repair. J. Biol. Chem. 276, 18665–18672 (2001).
Ford, J. M. & Hanawalt, P. C. Expression of wild-type p53 is required for efficient global genomic nucleotide excision repair in UV-irradiated human fibroblasts. J. Biol. Chem. 272, 28073–28080 (1997).
Proietti De Santis, L. et al. Transcription coupled repair efficiency determines the cell cycle progression and apoptosis after UV exposure in hamster cells. DNA Repair 1, 209–223 (2002).
D'Errico, M. et al. Apoptosis and efficient repair of DNA damage protect human keratinocytes against UVB. Cell Death Differ. 10, 754–756 (2003).
Bregman, D. B. et al. UV-induced ubiquitination of RNA polymerase II: a novel modification deficient in Cockayne syndrome cells. Proc. Natl Acad. Sci. USA 93, 11586–11590 (1996).
Lee, K. B., Wang, D., Lippard, S. J. & Sharp, P. A. Transcription-coupled and DNA damage-dependent ubiquitination of RNA polymerase II in vitro. Proc. Natl Acad. Sci. USA 99, 4239–4244 (2002).
Yang, L. J., Jiang, H. & Rangel, K. M. RNA polymerase II stalled on a DNA template during transcription elongation is ubiquitinated and the ubiquitination facilitates displacement of the elongation complex. Int. J. Oncol. 22, 683–689 (2003).
Tremeau-Bravard, A., Riedl, T., Egly, J. M. & Dahmus, M. E. Fate of RNA polymerase II stalled at a cisplatin lesion. J. Biol. Chem. 279, 7751–7759 (2004).
Lommel, L., Bucheli, M. E. & Sweder, K. S. Transcription-coupled repair in yeast is independent from ubiquitylation of RNA pol II: implications for Cockayne's syndrome. Proc. Natl Acad. Sci. USA 97, 9088–9092 (2000).
Lee, K. B. & Sharp, P. A. Transcription-dependent polyubiquitination of RNA polymerase II requires lysine 63 of ubiquitin. Biochemistry 43, 15223–15229 (2004).
D'Errico, M. et al. Differential role of transcription-coupled repair in UVB-induced response of human fibroblasts and keratinocytes. Cancer Res. 65, 432–438 (2005).
Ljungman, M. & Zhang, F. Blockage of RNA polymerase as a possible trigger for u. v. light-induced apoptosis. Oncogene 13, 823–831 (1996).
Selby, C. P. & Sancar, A. Cockayne syndrome group B protein enhances elongation by RNA polymerase II. Proc. Natl Acad. Sci. USA 94, 11205–11209 (1997).
Hara, R., Selby, C. P., Liu, M., Price, D. H. & Sancar, A. Human transcription release factor 2 dissociates RNA polymerases I and II stalled at a cyclobutane thymine dimer. J. Biol. Chem. 274, 24779–24786 (1999).
Shilatifard, A. Factors regulating the transcriptional elongation activity of RNA polymerase II. FASEB J. 12, 1437–1446 (1998).
Beerens, N., Hoeijmakers, J. H., Kanaar, R., Vermeulen, W. & Wyman, C. The CSB protein actively wraps DNA. J. Biol. Chem. 280, 4722–4729 (2005).
Groisman, R. et al. The ubiquitin ligase activity in the DDB2 and CSA complexes is differentially regulated by the COP9 signalosome in response to DNA damage. Cell 113, 357–367 (2003).
Kamiuchi, S. et al. Translocation of Cockayne syndrome group A protein to the nuclear matrix: possible relevance to transcription-coupled DNA repair. Proc. Natl Acad. Sci. USA 99, 201–206 (2002).
McDowell, M., Nguyen, T. & Cleaver, J. E. A single-site mutation in the XPAC gene alters photoproduct recognition. Mutagenesis 8, 155–161 (1993).
Itin, P. H., Sarasin, A. & Pittelkow, M. R. Trichothiodystrophy: update on the sulfur-deficient brittle hair syndromes. J. Am. Acad. Dermatol. 44, 891–920 (2001).
Mondello, C. et al. Molecular analysis of the XP-D-gene in Italian families with patients affected by trichothiodystrophy and xeroderma pigmentosum group D. Mutat. Res. 314, 159–165 (1994).
Broughton, B. C., Steingrimsdottir, H., Weber, C. A. & Lehmann, A. R. Mutations in the xeroderma pigmentosum group D DNA repair/transcription gene in patients with trichothiodystrophy. Nature Genet. 7, 189–194 (1994).
Giglia-Mari, G. et al. A new, tenth subunit of TFIIH is responsible for the DNA repair syndrome trichothiodystrophy group A. Nature Genet. 36, 714–719 (2004).
Clarkson, S. G. The XPG story. Biochimie 85, 1113–1121 (2003).
Gaillard, P. H. & Wood, R. D. Activity of individual ERCC1 and XPF subunits in DNA nucleotide excision repair. Nucleic Acids Res. 29, 872–879 (2001).
Mone, M. J. et al. In vivo dynamics of chromatin-associated complex formation in mammalian nucleotide excision repair. Proc. Natl Acad. Sci. USA 101, 15933–15937 (2004).
Niedernhofer, L. J. et al. The structure-specific endonuclease Ercc1–Xpf is required to resolve DNA interstrand crosslink-induced double-strand breaks. Mol. Cell. Biol. 24, 5776–5787 (2004).
Zhu, X. D. et al. ERCC1/XPF removes the 3′ overhang from uncapped telomeres and represses formation of telomeric DNA-containing double minute chromosomes. Mol. Cell 12, 1498–1498 (2003).
Thorel, F. et al. Definition of a short region of XPG necessary for TFIIH interaction and stable recruitment to sites of UV damage. Mol. Cell. Biol. 24, 10670–10680 (2004).
Sijbers, A. M. et al. Homozygous R488W point mutation in the XPF gene of a patient with xeroderma pigmentosum and late-onset neurologic disease. J. Invest. Dermatol. 110, 832–836 (1998).
Tian, M., Shinkura, R., Shinkura, N. & Alt, F. W. Growth retardation, early death, and DNA repair defects in mice deficient for the nucleotide excision repair enzyme XPF. Mol. Cell. Biol. 24, 1200–1205 (2004).
Toueille, M. & Hubscher, U. Regulation of the DNA replication fork: a way to fight genomic instability. Chromosoma 113, 113–125 (2004).
Nowak, M. A. et al. The role of chromosomal instability in tumor initiation. Proc. Natl Acad. Sci. USA 99, 16226–16231 (2002).
Cleaver, J. E. Xeroderma pigmentosum: variants with normal DNA repair and normal sensitivity to ultraviolet light. J. Invest. Dermatol. 58, 124–128 (1972).
Johnson, R. E., Kondratick, C. M., Prakash, S. & Prakash, L. hRAD30 mutations in the variant form of xeroderma pigmentosum. Science 264, 263–265 (1999).
Masutani, C. et al. The XPV (xeroderma pigmentosum variant) gene encodes human DNA polymerase η. Nature 399, 700–704 (1999).
Kannouche, P. et al. Localization of DNA polymerases μ and ι to the replication machinery is tightly coordinated in human cells. EMBO J. 22, 1223–1233 (2003).
Kannouche, P. L., Wing, J. & Lehmann, A. R. Interaction of human DNA polymerase μ with monoubiquitinated PCNA: a possible mechanism for the polymerase switch in response to DNA damage. Mol. Cell 14, 491–500 (2004).
Faili, A. et al. Induction of somatic hypermutation in immunoglobulin genes is dependent on DNA polymerase ι. Nature 419, 944–947 (2002).
Franklin, A., Milburn, P. J., Blanden, R. V. & Steele, E. J. Human DNA polymerase η, an A-T mutator in somatic hypermutation of rearranged immunoglobulin genes, is a reverse transcriptase. Immunol. Cell Biol. 82, 219–225 (2004).
Zeng, X. et al. DNA polymerase η is an A-T mutator in somatic hypermutation of immunoglobulin variable genes. Nature Immunol. 2, 537–541 (2001).
Zeng, X., Negrete, G. A., Kasmer, C., Yang, W. W. & Gearhart, P. J. Absence of DNA polymerase η reveals targeting of C mutations on the nontranscribed strand in immunoglobulin switch regions. J. Exp. Med. 199, 917–924 (2004).
Kannouche, P. et al. Domain structure, localization, and function of DNA polymerase η, defective in xeroderma pigmentosum variant cells. Genes Dev. 15, 158–172 (2001).
Sarkaria, J. N. et al. Inhibition of ATM and ATR kinase activities by the radiosensitizing agent, caffeine. Cancer Res. 59, 4375–4382 (1999).
Cleaver, J. E. et al. Increased UV sensitivity and chromosomal instability related to p53 function in the xeroderma pigmentosum variant. Cancer Res. 59, 1102–1108 (1999).
Laposa, R. R., Feeney, L. & Cleaver, J. E. Recapitulation of the cellular xeroderma pigmentosum-variant phenotype using short interfering RNA for DNA polymerase H. Cancer Res. 63, 3909–3912 (2003).
Limoli, C. L., Giedzinski, E., Morgan, W. F. & Cleaver, J. E. Polymerase η deficiency in the XP variant uncovers an overlap between the S phase checkpoint and double strand break repair. Proc. Natl Acad. Sci. USA 97, 7939–7946 (2000).
Limoli, C. L., Giedzinski, E., Bonner, W. M. & Cleaver, J. E. UV-induced replication arrest in the xeroderma pigmentosum variant leads to double strand breaks, γ-H2Ax formation, and Mre11 relocalization. Proc. Natl Acad. Sci. USA 99, 233–238 (2002).
Lee, S., Cavallo, L. & Griffith, J. Human p53 binds Holliday junctions strongly and facilitates their cleavage. J. Biol. Chem. 272, 7532–7539 (1997).
Jayaraman, J. & Prives, C. Activation of p53 sequence-specific DNA binding by short single strands of DNA requires the p53 C-terminus. Cell 81, 1021–1029 (1995).
Dutta, A., Ruppert, J. M., Aster, J. C. & Winchester, E. Inhibition of DNA replication factor RPA by p53. Nature 365, 79–82 (1993).
Buchhop, S. et al. Interaction of p53 with the human rad51 protein. Nucleic Acids Res. 25, 3868–3874 (1997).
Limoli, C. L., Giedzinski, E. & Cleaver, J. E. Alternative recombination pathways in UV-irradiated XP Variant cells. Oncogene 7 Mar 2005 (1038/sj.onc.1208515).
Neuspikel, T. & Hanawalt, P. C. Terminally differentiated human neurons repair transcribed genes but display attenuated global DNA repair and modulation of repair gene expression. Mol. Cell. Biol. 20, 1562–1570 (2000).
Wang, Q. E. et al. Cellular ubiquitination and proteasomal functions positively modulate mammalian nucleotide excision repair. Mol. Carcinog. 42, 53–64 (2005).
Welsh, C. et al. Reduced levels of XPA, ERCC1 and XPF DNA repair proteins in testis tumor cell lines. Int. J. Cancer 110, 352–361 (2004).
Thakur, M. et al. DNA polymerase η undergoes alternative splicing, protects against UV sensitivity and apoptosis, and suppresses Mre11-dependent recombination. Genes Chromosom. Cancer 32, 222–235 (2001).
Barrett, S. F., Robbins, J. H. Tarone, R. E. & Kraemer, K. H. Evidence for defective repair of cyclobutane dimers with normal repair of other photoproducts in a transcriptionally active gene transfected into Cockayne syndrome cells. Mutat. Res. 255, 281–291 (1991).
Parris, C. H. & K. H. Kraemer . Ultraviolet-light induced mutations in Cockayne syndrome cells are primarily caused by cyclobutane dimer photoproducts while repair of other photoproducts is normal. Proc. Natl Acad. Sci. USA 90, 7260–7264 (1993).
Rajagopalan, H. & Lengauer, C. Aneuploidy and cancer. Nature 432, 338–341 (2004).
Spatz, A., Giglia-Mari, G., Benhamou, S. & Sarasin, A. Association between DNA repair-deficiency and high level of p53 mutations in melanoma of xeroderma pigmentosum. Cancer Res. 61, 2480–2486 (2001).
Bodak, N. et al. High levels of patched gene mutations in basal-cell carcinomas from patients with xeroderma pigmentosum. Proc. Natl Acad. Sci. USA 96, 5117–5122 (1999).
Kuraoka, I. et al. Removal of oxygen free-radical-induced 5′,8-purine cyclodeoxynucleosides from DNA by the nucleotide excision-repair pathway in human cells. Proc. Natl Acad. Sci. USA 97, 3832–3837 (2000).
Weeda, G. et al. The XPB subunit of repair/transcription factor TFIIH directly interacts with SUG1, a subunit of the 26S proteasome and putative transcription factor. Nucleic Acids Res. 25, 2274–2283 (1997).
Schaeffer, L. et al. DNA repair helicase: a component of BTF2 (TFIIH) basic transcription factor. Science 260, 58–63 (1993).
Keriel, A., Stary, A., Sarasin, A., Rochette-Egly, C. & Egly, J. -M. XPD mutations prevent TFIIH-dependent transactivation by nuclear receptors and phosphorylation of RARα. Cell 109, 125–135 (2002).
Taylor, E. M. et al. Xeroderma pigmentosum and trichothiodystrophy are associated with different mutations in the XPD (ERCC2) repair/transcription gene. Proc. Natl Acad. Sci. USA 94, 8658–8663 (1997).
Dubaele, S. et al. Basal transcription defect discriminates between xeroderma pigmentosum and trichothiodystrophy in XPD patients. Mol. Cell 11, 1635–1646 (2003).
Viprakasit, V. et al. Mutations in the general transcription factor TFIIH result in β-thalassaemia in individuals with trichothiodystrophy. Hum. Mol. Genet. 10, 2797–2802 (2001).
Cline, S. D., Riggins, J. N., Tornaletti, S., Marnett, L. J. & Hanawalt, P. C. Malondialdehyde adducts in DNA arrest transcription by T7 RNA polymerase and mammalian RNA polymerase II. Proc. Natl Acad. Sci. USA 101, 7275–7280 (2004).
Hayashi, M. et al. Oxidative stress and disturbed glutamate transport in hereditary nucleotide repair disorders. J. Neuropathol. Exp. Neurol. 60, 350–356 (2001).
de Waard, H. et al. Cell type-specific hypersensitivity to oxidative damage in CSB and XPA mice. DNA Repair 2, 13–25 (2003).
Chen, P. et al. Oxidative stress is responsible for deficient survival and dendritogenesis in purkinje neurons from ataxia-telangiectasia mutated mutant mice. J. Neurosci. Res. 23, 11453–11460 (2003).
Sun, X. Z., Harada, Y. N., Takahashi, S., Shiomi, N. & Shiomi, T. Purkinje cell degeneration in mice lacking the xeroderma pigmentosum group G gene. J. Neurosci. Res. 64, 348–354 (2001).
Ciechanover, A. & Brundin, P. The ubiquitin proteasome system in neurodegenerative diseases: sometimes the chicken, sometimes the egg. Neuron 40, 427–446 (2003).
Lopez Salon, M., Morelli, L., Castano, E. M., Soto, E. F. & Pasquini, J. M. Defective ubiquitination of cerebral proteins in Alzheimer's disease. J. Neurosci. Res. 62, 302–310 (2000).
von Coelln, R., Dawson, V. L. & Dawson, T. M. Parkin-associated Parkinson's disease. Cell Tissue Res. 318, 175–184 (2004).
Friedberg, E. C., Meira, L. B. & Cheo, D. L. Database of mouse strains carrying targeted mutations in genes affecting cellular responses ot DNA damage. Version 2. Mutat. Res. 407, 217–226 (1998).
Itoh, T., Cado, D., Kamide, R. & Linn, S. DDB2 gene disruption leads to skin tumors and resistance to apoptosis after exposure to ultraviolet light but not a chemical carcinogen. Proc. Natl Acad. Sci. USA 101, 2052–2057 (2004).
Cheo, D. L. et al. Ultraviolet B radiation-induced skin cancer in mice defective in the Xpc, Trp53, and Apex (HAP1) genes: genotype-specific effects on cancer predisposition and pathology of tumors. Cancer Res. 60, 1580–1584 (2000).
Berg, R. J. et al. Impact of global genome repair versus transcription-coupled repair on ultraviolet carcinogenesis in hairless mice. Cancer Res. 60, 2858–2863 (2000).
van der Horst, G. T. et al. UVB radiation-induced cancer predisposition in Cockayne syndrome group A (Csa) mutant mice. DNA Repair 1, 143–157 (2002).
Berg, R. J. W., Vries, A. D., Steeg, H. V. & Gruijl, F. R. D. Relative susceptibilities of XPA knockout mice and their heterozygous and wild-type littermates to UVB-induced skin cancer. Cancer Res. 57, 581–584 (1997).
De Vries, A. et al. Increased susceptibility to ultraviolet-B and carcinogens of mice lacking the DNA excision repair gene XPA. Nature 377, 169–173 (1995).
Tanaka, K. et al. UV-induced skin carcinogenesis in xeroderma pigmentosum group A (XPA) gene-knockout mice with nucleotide excision repair-deficiency. Mutat. Res. 477, 31–40 (2001).
Murai, M. et al. Early postnatal ataxia and abnormal cerebellar development in mice lacking Xeroderma pigmentosum Group A and Cockayne syndrome Group B DNA repair genes. Proc. Natl Acad. Sci. USA 98, 13379–13384 (2001).
de Boer, J. et al. Premature aging in mice deficient in DNA repair and transcription. Science 296, 1276–1279 (2002).
Shiomi, N. et al. Severe growth retardation and short life-span of double mutant mice lacking Xpa and exon 15 of Xpg. DNA Repair 4, 351–357 (2005).
de Boer, J. et al. A mouse model for the basal transcription/DNA repair syndrome trichothiodystrophy. Mol. Cell 1, 981–990 (1998).
Mitchell, J. R., Hoeijmakers, J. H. & Niedernhofer, L. J. Divide and conquer: nucleotide excision repair battles cancer and ageing. Curr. Opin. Cell Biol. 15, 232–240 (2003).
Shiomi, N. et al. Identification of the XPG region that causes the onset of Cockayne syndrome by using Xpg mutant mice generated by the cDNA-mediated knock-in method. Mol. Cell. Biol. 24, 3712–3719 (2004).
Prasher, J. M. et al. Reduced hematopoietic reserves in DNA interstrand crosslink repair-deficient Ercc1−/− mice. EMBO J. 24, 861–871 (2005).
Delbos, F. et al. Contribution of DNA polymerase η to immunoglobulin gene hypermutation in the mouse. J. Exp. Med. 201, 1191–1196 (2005).
McDonald, J. P. et al. 129-derived strains of mice are deficient in DNA polymerase ι and have normal immunoglobulin hypermutation. J. Exp. Med. 198, 635–643 (2003).
Osterod, M. et al. A global DNA repair mechanism involving the Cockayne syndrome B (CSB) gene product can prevent the in vivo accumulation of endogenous oxidative DNA base damage. Oncogene 21, 8232–8239 (2002).
Tebbs, R. S. et al. Requirement for the Xrcc1 DNA base excision repair gene during early mouse development. Dev. Biol. 208, 513–529 (1999).
Tebbs, R. S., Thompson, L. H. & Cleaver, J. E. Rescue of Xrcc1 knockout mouse embryo lethality by transgene complementation. DNA Repair 2, 1405–1417 (2003).
Yang, Y. & Herrup, K. Loss of neuronal cell cycle control in ataxia-telangiectasia:a unified disease mechanism. J. Neuroscience 25, 2522–2529 (2005).
Rangarajan, A., Hong, H. J., Gifford, A. & Weinberg, R. A. Species and cell type-specific requirements for cellular transformation. Cancer Cell 6, 171–183 (2004).
Blackburn, E. H. Structure and function of telomeres. Nature 350, 569–573 (1991).
Marchetto, M. C., Muotri, A. R., Burns, D. K., Friedberg, E. C. & Menck, C. F. Gene transduction in skin cells: preventing cancer in xeroderma pigmentosum mice. Proc. Natl Acad. Sci. USA 101, 17759–17764 (2004).
Cleaver, J. E., Volpe, J. P. G., Charles, W. C. & Thomas, G. H. Prenatal diagnosis of xeroderma pigmentosum and Cockayne syndrome. Prenat. Diagn. 14, 921–928 (1994).
Yarosh, D. et al. Effect of topically applied T4 endonuclease V in liposomes on skin cancer in xeroderma pigmentosum: a randomised study. Xeroderma Pigmentosum Study Group. Lancet 357, 926–929 (2001).
Kraemer, K. H., DiGiovanna, J. J. & Peck, G. L. Chemoprevention of skin cancer in xeroderma pigmentosum. J. Dermatol. 19, 715–718 (1992).
Cleaver, J. E. Defective repair replication in xeroderma pigmentosum. Nature 218, 652–656 (1968).
Daughdrill, G. W. et al. Chemical shift changes provide evidence for overlapping single-stranded DNA- and XPA-binding sites on the 70 kDa subunit of human replication protein A. Nucleic Acids Res. 31, 4176–4183 (2003).
Ling, H., Boudsocq, F., Woodgate, R. & Yang, W. Crystal structure of a Y-family DNA polymerase in action. a mechanism for error-prone and lesion-bypass replication. Cell 107, 91–102 (2001).
Nance, M. A. & Berry, S. A. Cockayne syndrome: review of 140 cases. Am. J. Med. Genet. 42, 68–84 (1992).
Horibata, K. et al. Complete absence of Cockayne syndrome group B gene product gives rise to UV-sensitive syndrome but not Cockayne syndrome. Proc. Natl Acad. Sci. USA 101, 15410–15415 (2004).
Colella, S., Nardo, T., Botta, E., Lehmann, A. R. & Stefanini, M. Identical mutations in the CSB gene associated with either Cockayne syndrome or the DeSanctis-cacchione variant of xeroderma pigmentosum. Hum. Mol. Genet. 9, 1171–1175 (2000).
Lommel, L., Chen, L., Madura, K. & Sweder, K. The 26S proteasome negatively regulates the level of overall genomic nucleotide excision repair. Nucleic Acids Res. 28, 4839–4845 (2000).
Semple, C. A., Group., R. G. & Members., G. The comparative proteomics of ubiquitination in mouse. Genome Res. 13, 1389–1394 (2003).
Hochstrasser, M. Ubiquitin-dependent protein degradation. Ann. Rev. Genet. 30, 403–409 (1996).
Wilkinson, K. D. Ubiquitination and deubiquitination: targeting of proteins for degradation by the proteasome. Semin. Cell Dev. Biol. 11, 141–148 (2000).
Chen, Z., Zhang, Y., Douglas, L. & Zhou, P. UV-damaged DNA-binding proteins are targets of CUL-4A-mediated ubiquitination and degradation. J. Biol. Chem. 276, 48175–48182 (2001).
Schauber, C. et al. Rad23 links DNA repair to the ubiquitin/proteasome pathway. Nature 391, 715–718 (1998).
Chen, L., Shinde, U., Ortolan, T. G. & Madura, K. Ubiquitin-associated (UBA) domains in Rad23 bind ubiquitin and promote inhibition of multi-ubiquitin chain assembly. EMBO Rep. 2, 933–938 (2001).
Gillette, T. G. et al. The 19S complex of the proteasome regulates nucleotide excision repair in yeast. Genes Dev. 15, 1528–1539 (2001).
Russell, S. J., Reed, S. H., Huang, W., Friedberg, E. C. & Johnston, S. A. The 19S regulatory complex of the proteasome functions independently of proteolysis in nucleotide excision repair. Mol. Cell 3, 687–695 (1999).
van Laar, T., van der Eb, A. J. & Terleth, C. A role for Rad23 proteins in 26S proteasome-dependent protein degradation? Mutat. Res. 499, 53–61 (2002).
Hoege, C., Pfander, B., Moldovan, G. L., Pyrowolakis, G. & Jentsch, S. RAD6-dependent DNA repair is linked to modification of PCNA by ubiquitin and SUMO. Nature 419, 135–141 (2002).
Steitz, T. A. DNA polymerases: structural diversity and common mechanisms. J. Biol. Chem. 274, 17395–17398 (1999).
Ohmori, H. et al. The Y-family of DNA polymerases. Mol. Cell 8, 7–8 (2001).
Trincao, J. et al. Structure of the catalytic core of S. cerevisiae DNA polymerase η: implications for translesion synthesis. Mol. Cell 8, 417–426 (2001).
McCulloch, S. D. et al. Preferential cis-syn thymine dimer bypass by DNA polymerase η occurs with biased fidelity. Nature 428, 97–100 (2004).
Johnson, R. E., Washington, M. T., Prakash, S. & Prakash, L. Fidelity of human DNA polymerase η. J. Biol. Chem. 275, 7447–7450 (2000).
Matsuda, T., Bebenek, K., Masutani, C., Hanoaka, F. & Kunkel, T. A. Low fidelity DNA synthesis by human DNA polymerase η. Nature 404, 1011–1013 (2000).
Johnson, R. E., Washington, M. T., Haracska, L., Prakash, S. & Prakash, L. Eukaryotic polymerases ι and ζ act sequentially to bypass DNA lesions. Nature 406, 1015–1019 (2000).
Woodgate, R. Evolution of the two–step model for UV-mutagenesis. Mutat. Res. 485, 83–92 (2001).
Wang, Y. C., Maher, V. M. & McCormick, J. J. Xeroderma pigmentosum variant cells are less likely than normal cells to incorporate dAMP opposite photoproducts during replication of UV-irradiated plasmids. Proc. Natl Acad. Sci. USA 88, 7810–7814 (1991).
Cleaver, J. E. Sensitivity of excision repair in normal human, xeroderma pigmentosum variant and Cockayne's syndrome fibroblasts to inhibition by cytosine arabinoside. J. Cell Physiol. 108, 163–173 (1981).
Dingman, T. & Kakunaga, T. DNA strand breaking and rejoining in response to ultraviolet light in normal and xeroderma pigmentosum cells. Int. J. Radiat. Biol. 30, 55–66 (1976).
Cleaver, J. E. & Mitchell, D. L. in Cancer Medicine Vol. 1 (eds. Kufe, D. W. et al.) 303–311 (BC Becher Inc., Hamilton, Ontario, 2003).
Acknowledgements
This article was written with support from a grant from the National Institutes of Environmental Health Sciences, and generous gifts from the Xeroderma Pigmentosum Society and the Luke O'Brien Foundation.
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Cleaver, J. Cancer in xeroderma pigmentosum and related disorders of DNA repair. Nat Rev Cancer 5, 564–573 (2005). https://doi.org/10.1038/nrc1652
Issue Date:
DOI: https://doi.org/10.1038/nrc1652
This article is cited by
-
TGFβ signaling links early life endocrine-disrupting chemicals exposure to suppression of nucleotide excision repair in rat myometrial stem cells
Cellular and Molecular Life Sciences (2023)
-
Increased risk of internal tumors in DNA repair-deficient xeroderma pigmentosum patients: analysis of four international cohorts
Orphanet Journal of Rare Diseases (2022)
-
Cancer Predisposition Genes in Adolescents and Young Adults (AYAs): a Review Paper from the Italian AYA Working Group
Current Oncology Reports (2022)
-
Generation of 3′-OH terminal–triggered encoding of multicolor fluorescence for simultaneous detection of different DNA glycosylases
Analytical and Bioanalytical Chemistry (2022)
-
Mitophagy in tumorigenesis and metastasis
Cellular and Molecular Life Sciences (2021)
